Skip to main content
. 2020 Aug 18;11:565. doi: 10.3389/fendo.2020.00565

Table 1.

Demographic and clinical characteristics of the study population by hypothyroidism status (n = 3,703).

Hypothyroidism (n = 251) n (%) Without hypothyroidism (n = 3,452) n (%) p-value
Age (years ± SD) 65.0 (± 16.9) 56.4 (±18.2) <0.001
Female 173 (68.9) 1,481 (42.9) <0.001
Race <0.001
    NHW 114 (45.4) 899 (26.0)
    NHB 39 (15.5) 953 (27.6)
    Other/ unknown 98 (39.0) 1,600 (46.4)
Smoking <0.001
    Never 153 (61) 1,991 (57.7)
    Former 72 (28.7) 641 (18.6)
    Current 7 (2.8) 186 (5.4)
    Unknown 19 (7.6) 634 (18.4)
BMI <0.001
     <25 74 (29.5) 771 (22.3)
    25-30 75 (29.9) 981 (28.4)
    > 30 87 (34.7) 985 (28.5)
    Unknown 15 (6.0) 715 (20.7)
Number of Comorbidities* <0.001
    0 55 (21.9) 1,305 (37.8)
    1 52 (20.7) 786 (22.8)
    2 40 (15.9) 575 (16.7)
    >2 104 (41.4) 786 (22.8)
Hospital admission 171 (68.1) 1,844 (53.4) <0.001

NHB, Non-Hispanic Black; NHW, Non-Hispanic White; SD, standard deviation.

*

Comorbidities include hypertension, coronary artery disease, atrial fibrillation, congestive heart failure, peripheral vascular disease, cerebrovascular accident/ transient ischemic attack, dementia, diabetes, chronic kidney disease stage III or greater, malignancy (including all types of cancer as well as lymphoma and leukemia), asthma, chronic obstructive pulmonary disease and prior venous thromboembolism.